Proteomic Analysis of the Molecular Mechanism of Lovastatin Inhibiting the Growth of Nasopharyngeal Carcinoma Cells

Yongzhen Mo(Central South University), Can Guo(Ministry of Agriculture), Zhaoyang Zeng(Shenzhen Academy of Robotics), Guiyuan Li(Xuzhou Medical College), Yong Li(Baylor College of Medicine), Zheng Li(Hunan University of Science and Technology), Yumin Wang(Central South University), Wei Xiong(Central South University), Xiayu Li(Central South University), Xiaolu Ge(Shanghai Jiao Tong University), Xiaoling Li(Third Xiangya Hospital), Fang Xiong(Nanjing Maternity and Child Health Care Hospital)
Journal of Cancer
January 1, 2019
10.7150/jca.30454
Cited by 57

Related Papers

Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619